- £1.81bn
- £2.02bn
- £672.80m
- 82
- 13
- 84
- 66
Annual income statement for Genus, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 574 | 593 | 690 | 669 | 673 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 218 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 527 | 544 | 649 | 662 | 634 |
| Operating Profit | 47.7 | 49.4 | 40.5 | 6.4 | 39.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 55.8 | 48.4 | 39.4 | 5.5 | 28.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 46.8 | 36.7 | 31.8 | 2.4 | 19.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 47.3 | 40.9 | 33.3 | 7.9 | 19.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 47.3 | 40.9 | 33.3 | 7.9 | 19.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.9 | 0.711 | 0.754 | 0.446 | 0.594 |
| Dividends per Share |